Видео ютуба по тегу Model-Informed Drug Development

Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development

Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development
SOT Weekly Update 9-12-2024

SOT Weekly Update 9-12-2024
How Can Model Informed Drug Development Impact Your Program?

How Can Model Informed Drug Development Impact Your Program?
ICOP 2025 Highlights | Advancing Pharmacometrics & Drug Development Globally

ICOP 2025 Highlights | Advancing Pharmacometrics & Drug Development Globally
Module 8 – Part 2: FDA Feedback on DHT- based COA Submissions

Module 8 – Part 2: FDA Feedback on DHT- based COA Submissions
THE ROLE OF MODELLING

THE ROLE OF MODELLING
Module 8 – Part 1: Introduction to Digital Health

Module 8 – Part 1: Introduction to Digital Health
Challenges and Directions in Applying Model-based Drug Discovery & Development

Challenges and Directions in Applying Model-based Drug Discovery & Development
Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment

Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment
Asking the Right Questions of Your Data: Experiences with Model-informed Development Approaches

Asking the Right Questions of Your Data: Experiences with Model-informed Development Approaches
Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.
Value Focused MIDD: Influenza Model-informed Drug Development Program

Value Focused MIDD: Influenza Model-informed Drug Development Program
What is the importance of model-informed drug (MIDD) development?

What is the importance of model-informed drug (MIDD) development?
Innovative Trial Design Approaches: Model Informed Drug Development in Rare & Neurological Diseases

Innovative Trial Design Approaches: Model Informed Drug Development in Rare & Neurological Diseases
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Using Model Based Meta Analysis to Inform Drug Development for Auto Immune Diseases

Using Model Based Meta Analysis to Inform Drug Development for Auto Immune Diseases
Triple Helix Expertise Exchange Workshop on Modeling Drug-Device Interaction

Triple Helix Expertise Exchange Workshop on Modeling Drug-Device Interaction